OACC (Oaktree Acquisition III Life Sciences) EPS (Basic): $0.30 (TTM As of Mar. 2026)


OACC Oaktree Acquisition Corp III Life Sciences OACC
15 GF Score
Price $10.67
View Full Analysis

What is Oaktree Acquisition III Life Sciences EPS (Basic)?

Oaktree Acquisition III Life Sciences OACC -0.28% 15 EPS (Basic) is $0.30 as of Mar. 2026. GuruFocus rates OACC with a GF Score™ of 15/100.

Oaktree Acquisition III Life Sciences's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was $0.06. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.30.

Oaktree Acquisition III Life Sciences's EPS (Diluted) for the three months ended in Mar. 2026 was $0.06. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $0.30.

Oaktree Acquisition III Life Sciences's EPS without NRI for the three months ended in Mar. 2026 was $0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 0.30.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Oaktree Acquisition III Life Sciences  (NAS:OACC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Oaktree Acquisition III Life Sciences EPS (Basic) Related Terms

Oaktree Acquisition III Life Sciences EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Oaktree Acquisition III Life Sciences's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oaktree Acquisition III Life Sciences EPS (Basic) Chart

Oaktree Acquisition III Life Sciences Annual Data
Trend Dec24 Dec25
EPS (Basic)
0.00 0.30

Oaktree Acquisition III Life Sciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial 0.07 0.08 0.08 0.08 0.06
OACC
15GF Score
Oaktree Acquisition Corp III Life Sciences OACC
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oaktree Acquisition III Life Sciences EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Oaktree Acquisition III Life Sciences's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(7.289-0)/24.583
=0.30

Oaktree Acquisition III Life Sciences's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(1.394-0)/24.583
=0.06

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $0.30 mean?
Oaktree Acquisition III Life Sciences (OACC) has a EPS (Basic) of $0.30 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Oaktree Acquisition III Life Sciences and its competitors.
Is Oaktree Acquisition III Life Sciences' EPS (Basic) too high?
Oaktree Acquisition III Life Sciences' current EPS (Basic) is $0.30. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Oaktree Acquisition III Life Sciences' EPS (Basic) compare to RAAQ and FACT?
Oaktree Acquisition III Life Sciences' EPS (Basic) of $0.30 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Diversified Financial Services company?
A good EPS (Basic) depends on the Diversified Financial Services industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Oaktree Acquisition III Life Sciences and its competitors. Oaktree Acquisition III Life Sciences's current EPS (Basic) is $0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oaktree Acquisition III Life Sciences stock overvalued right now?
Oaktree Acquisition III Life Sciences (OACC) has a current EPS (Basic) of $0.30. The current EPS (Basic) is $0.30. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current EPS (Basic) is $0.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oaktree Acquisition III Life Sciences Business Description

Address 333 South Grand Avenue, 28th Floor, Los Angeles, CA, USA, 90071
Oaktree Acquisition Corp III Life Sciences is a blank check company.
15GF Score

Get the complete analysis for OACC

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.67
Price